Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma

被引:19
作者
Fournier, Jean-Francois [1 ]
Bhurruth-Alcor, Yushma [1 ]
Musicki, Branislav [1 ]
Aubert, Jerome [1 ]
Aurelly, Michele [1 ]
Bouix-Peter, Claire [1 ]
Bouquet, Karinne [1 ]
Chantalat, Laurent [1 ]
Delorme, Marion [1 ]
Drean, Benedicte [1 ]
Duvert, Gwenaelle [1 ]
Fleury-Bregeot, Nicolas [2 ]
Gauthier, Blanche [1 ]
Grisendi, Karine [1 ]
Harris, Craig S. [1 ]
Hennequin, Laurent F. [1 ]
Isabet, Tatiana [3 ]
Joly, Florence [1 ]
Lafitte, Guillaume [1 ]
Millois, Corinne [1 ]
Morgentin, Remy [2 ]
Pascau, Jonathan [1 ]
Piwnica, David [1 ]
Rival, Yves [1 ]
Soulet, Catherine [1 ]
Thoreau, Etienne [1 ]
Tomas, Loic [1 ]
机构
[1] Nestle Skin Hlth R&D, 2400 Route Colles,BP 87, F-06902 Sophia Antipolis, France
[2] Edelris, 115 Ave Lacassagne, F-69003 Lyon, France
[3] Synchrotron Soleil, St Aubin BP 48, F-91192 Gif Sur Yvette, France
关键词
HDAC inhibitors; Squaramide; CTCL; Topical; Mycosis fungoides; DESIGN; CANCER;
D O I
10.1016/j.bmcl.2018.06.029
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of squaramide-based hydroxamic acids were designed, synthesized and evaluated against human HDAC enzyme. Squaramides were found to be potent in the Hut78 cell line, but initially suffered from low solubility. Leads with improved solubility and metabolic profiles were shown to be class I, IIB and IV selective.
引用
收藏
页码:2985 / 2992
页数:8
相关论文
共 23 条
[1]  
Acker MG., 2014, PERSPECT SCI, V1, P56, DOI [DOI 10.1016/J.PISC.2013.12.001, 10.1016/j.pisc.2013.12.001]
[2]   Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition [J].
Behera, Jagannath ;
Jayprakash, Venkatesan ;
Sinha, Barij Nayan .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (09) :731-750
[3]   A facile and rapid preparation hydroxamic acids by hydroxylaminolysis using DBU as base [J].
Beillard, Audrey ;
Bhurruth-Alcor, Yushma ;
Bouix-Peter, Claire ;
Bouquet, Karinne ;
Chambon, Sandrine ;
Clary, Laurence ;
Harris, Craig S. ;
Millois, Corinne ;
Mouis, Gregoire ;
Ouvry, Gilles ;
Pierre, Romain ;
Reitz, Arnaud ;
Tomas, Loic .
TETRAHEDRON LETTERS, 2016, 57 (20) :2165-2170
[4]   Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial [J].
Duvic, Madeleine ;
Dummer, Reinhard ;
Becker, Juergen C. ;
Poulalhon, Nicolas ;
Romero, Pablo Ortiz ;
Bernengo, Maria Grazia ;
Lebbe, Celeste ;
Assaf, Chalid ;
Squier, Margaret ;
Williams, Denise ;
Marshood, Miriam ;
Tai, Feng ;
Prince, H. Miles .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) :386-394
[5]  
Duvic M, 2007, BIOL-TARGETS THER, V1, P377
[6]   Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders [J].
Falkenberg, Katrina J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :673-691
[7]   Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne [J].
Fournier, Jean-Francois ;
Clary, Laurence ;
Chambon, Sandrine ;
Dumais, Laurence ;
Harris, Craig Steven ;
Millois, Corinne ;
Pierre, Romain ;
Talano, Sandrine ;
Thoreau, Etienne ;
Aubert, Jerome ;
Aurelly, Michele ;
Bouix-Peter, Claire ;
Brethon, Anne ;
Chantalat, Laurent ;
Christin, Olivier ;
Comino, Catherine ;
El-Bazbouz, Ghizlane ;
Ghilini, Anne-Laurence ;
Isabet, Tatiana ;
Lardy, Claude ;
Luzy, Anne-Pascale ;
Mathieu, Celine ;
Mebrouk, Kenny ;
Orfila, Danielle ;
Pascau, Jonathan ;
Reverse, Kevin ;
Roche, Didier ;
Rodeschini, Vincent ;
Hennequin, Laurent Francois .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (09) :4030-4051
[8]  
GAZDAR AF, 1980, BLOOD, V55, P409
[9]   Novel therapeutic agents for cutaneous T-Cell lymphoma [J].
Jain, Salvia ;
Zain, Jasmine ;
O'Connor, Owen .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
[10]   New Frontiers in Druggability [J].
Kozakov, Dima ;
Hall, David R. ;
Napoleon, Raeanne L. ;
Yueh, Christine ;
Whitty, Adrian ;
Vajda, Sandor .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) :9063-9088